Back
Open Access

Closing remarks.

Session: Cardiac AL amyloidosis: what’s on the horizon for optimised patient care?
Topic: Cardiac Amyloidosis
Speaker: Doctor A. Wechalekar (London, GB)
Sponsored by Alexion Pharmaceuticals, Inc.
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ashutosh Wechalekar

University College London Hospitals, London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

5 more presentations in this session

Welcome and Introductions.

Speaker: Professor P. Perrone-Filardi (Napoly, IT)

Access
Slides
Video
Like
Thumbnail

Unraveling cardiac amyloidosis.

Speaker: Associate Professor A. Kristen (Heidelberg, DE)

Access
Slides
Video
Like
Thumbnail

The role of the cardiologist in identifying cardiac amyloidosis.

Speaker: Professor M. Fontana (London, GB)

Access
Slides
Video
Like
Thumbnail

Approach to treating the organs and tissues in AL amyloidosis.

Speaker: Professor G. Palladini (Pavia, IT)

Access
Slides
Video
Like
Thumbnail

Q&A.

Access
Video
Like
Thumbnail

Access the full session

Cardiac AL amyloidosis: what’s on the horizon for optimised patient care?

Speakers: Doctor A. Wechalekar, Professor P. Perrone-Filardi, Associate Professor A. Kristen, Professor M. Fontana, Professor G. Palladini
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources